Xarelto, part of a new generation of anticoagulants, is a prescription medication used to reduce the risk of stroke and blood clots. It is currently at the center of a new lawsuit filed by the wife of a man who died because of uncontrollable bleeding. This is just the latest of a rapidly growing number of Xarelto bleeding lawsuits that are currently being filed through the country.
What is Xarelto, and what is the problem?
Xarelto, introduced in 2011, is a joint venture between Bayer and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. Kind of like Big 3 of the Miami Heat coming together. But in this case, the goal was not championships but to make gobs and gobs of money. Intended to replace warfarin (Coumadin), Xarelto has been promoted as superior to warfarin, and others like it, because it is easier to take and requires less frequent monitoring to maintain the correct dose. The downfall? First, it causes excessive bleeding. Second, there is no good reversal agent or antidote to stop bleeding should an event occur. While Bayer and Johnson & Johnson have indicated that they are working with a company to develop a reversal agent for Xarelto, there is not one currently available, making the drug unreasonably dangerous and defective.
This latest lawsuit claims that Johnson & Johnson never adequately warned that there was no reversal agent, while competitor medications, such as Warafin, have an antidote to stop bleeding events. Other lawsuits filed additionally allege that these individuals suffered severe and often fatal injuries as a result of uncontrollable hemorrhaging while taking Xarelto. Some further allege that the benefits provided by the medication do not justify the risks associated with the medication and that the drug should be recalled.
In addition to the side effects reported in adverse event claims to the FDA, allegations in pending lawsuits include:
- Death due to uncontrollable bleeding
- Brain hemorrhaging
- Rectal bleeding
- Intestinal bleeding
Another great concern is the fact that even after numerous reports of bleeding events that could not be stopped, Xarelto still does not have a “black box” warning – a type of warning that can appear on the package insert of a medication. The FDA requires pharmaceutical companies to place these boxed warning on the label or literature describing the medication, when a drug carries a significant risk of serious or even life-threatening adverse effects.
If you have suffered from serious complications of Xarelto such as internal bleeding, or you have lost a loved one or relative as the result of the medication, an attorney can help to determine if you have a potential claim, or if you are entitled to file a wrongful death lawsuit. The time to file a claim is often limited, so it is imperative to act now before the statute of limitations expires in your area. Contact one of our Xarelto lawyers at 800.553.8082 or online, here.